Pegbovigrastim treatment resulted in an economic benefit in a large randomized clinical trial in grazing dairy cows
This randomized controlled trial on 4 commercial grazing dairy farms investigated whether pegbovigrastim (PEG) treatment affected partial net return as calculated from milk revenues and costs for feed, medical treatments [clinical mastitis, uterine disease, and other diseases (i.e., any medical trea...
Zapisane w:
| 1. autor: | |
|---|---|
| Kolejni autorzy: | , , , , |
| Format: | article |
| Język: | angielski |
| Wydane: |
2022
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://hdl.handle.net/20.500.12008/48235 https://doi.org/10.3168/jds.2022-21974 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|
Podobne zapisy: Pegbovigrastim treatment resulted in an economic benefit in a large randomized clinical trial in grazing dairy cows
- Effect of pegbovigrastim on fertility and culling in grazing dairy cows and its association with prepartum nonesterified fatty acids
- Effect of pegbovigrastim on clinical mastitis and uterine disease during a full lactation in grazing dairy cows
- Increase in white blood cell counts by pegbovigrastim in primiparous and multiparous grazing dairy cows and the interaction with prepartum body condition score and non-esterified fatty acids concentration
- Advances in Knowledge of the Dairy Cow During the Transition Period in Uruguay: a Multidisciplinary Approach
- A polymorphism in the insulin-like growth factor 1 gene is associated with postpartum resumption of ovarian cyclicity in Holstein-Friesian cows under grazing conditions
- Effect of feeding management during the first 21 days postpartum, on direct and residual productive response and adaptation to grazing of multiparous Holstein dairy cows